我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
68
10 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
进行中(未招募)
2
2.9%
已完成
57
83.8%
尚未招募
8
11.8%
暂无批准数据
- The Calcutta High Court remanded ITC Limited's patent application for a non-electronic nicotine aerosol delivery device after the Controller rejected it under Section 3(b) of India's Patents Act citing public health concerns. - The Court ruled that patent grants should be independent of commercial restrictions and that the Controller violated natural justice by relying on undisclosed documents not presented during initial examination. - This decision establishes important precedent limiting the Patent Office's ability to make policy decisions based on public health concerns and clarifies that tobacco-related inventions cannot be automatically rejected under Section 3(b).